Practice areas

Capital markets; Private equity, venture capital & funds

Introduction

Nan Li (Li King Wang) is the managing partner and head of the Hong Kong practice at Tian Yuan Law Firm. Li has a broad range of corporate finance and mergers and acquisitions experience, with a focus on public and private securities offerings, cross-border mergers and acquisitions and private equity investments. Li was recognised as a leading capital markets lawyer by The Legal 500 and IFLR 1000, and was regarded as “expert in finance and mergers and acquisitions”. Li was praised by one client as “proficient in foreign and Chinese law, and has a deep understanding of customer business”, and is “a lawyer of sound judgment and great diligence and carefulness”.

Li has extensive experience in assisting clients in the field of the new economy and has accomplished many pioneering and innovative projects. He has assisted the listing and complex transactions of leading companies in the healthcare industry including Hygeia Healthcare, Jinxin Fertility, Gushengtang Holding, Gaush Medical, Chaoju Eye Care, Simcere Pharmaceuticals and CanSino Biologics; leading companies in the B2B/SaaS/Technology industry including Weimob, Youzan, Howkingtech, Samoyed Cloud, Chanjet Info Tech, Qinhuai Technology and Netjoy Holdings; and leading companies in the consumer and entertainment industries such as Zibuyu, Strawbear Entertainment, Yihai International, Zhou Hei Ya and Yadea Group.

Li is admitted to practice in Hong Kong and New York. He has obtained an LLM from the University of Pennsylvania Law School, as well as an LLB from the China University of Political Science and Law.

Back to China A-List 2022